Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Afirmus Biosource is a private life science distribution company that supplies laboratory and clinical research reagents, instruments, and related solutions to researchers and clinicians in Singapore and broader Southeast Asia. The company focuses on sourcing and distributing research-use products across cell biology, molecular biology, diagnostic testing, cell culture, induced pluripotent stem cell-derived cells, screening libraries, veterinary products, stable isotopes, and laboratory equipment. Rather than developing its own therapeutics, Afirmus operates as a commercial channel partner and regional distributor for international bioscience brands. Its customer base includes academic laboratories, government-funded research institutes, clinical research laboratories, and commercial-sector biomedical R&D groups. The company appears to position itself as a regional market-access and procurement partner for suppliers seeking distribution in Southeast Asia.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Afirmus Biosource.